The purpose of this research study is to test if HBI-8000 is a safe and effective addition to the treatment for melanoma. A standard of care treatment for your cancer is Nivolumab. Researchers want to determine if HBI-8000 will help Nivolumab slow down the growth of melanoma, shrink the size of tumor(s), or extend life when you are treated with HBI-8000 and Nivolumab.
To test if HBI-8000 is a safe and effective addition to the treatment for Melanoma
OPEN TO ACCRUAL